8-K
Current Report
Avalo Therapeutics, Inc. Filed Acc 0001628280-20-016660
Material agreement · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading cerc-20201116.htm…